Bayer sees lower 2023 operating profit due to inflation Agriculture and healthcare company Bayer said today that its operating earnings would likely decline in 2023, hurt by higher costs and the reversal of last … Business • 28 Feb
Bayer AG makes $698m settlement in US over pollution Bayer AG has finalised a $698 million settlement with the US state of Oregon to resolve claims that it polluted the environment with chemicals called … Business • 16 Dec 22
Bayer beats Q3 profit forecast on strong herbicide sale Agriculture and pharmaceuticals company Bayer has today reported better-than-expected quarterly earnings as surging demand for its herbicides made up for a decline in sales of … Business • 08 Nov 22
Bayer's farming business drives Q1 earnings beat Agriculture and pharmaceuticals company Bayer said its quarterly adjusted earnings rose by a better than expected 27.5% on strong gains at its seeds and pesticides … Business • 10 May 22
Bayer targets return to annual profits growth German diversified group Bayer is aiming for a return to growth in adjusted core earnings this year as higher profit at its agriculture division would … Business • 01 Mar 22
Bayer shares up after first trial win over Roundup Shares in Bayer rose this morning after the German agricultural and pharmaceuticals firm won its first trial over claims its Roundup weedkiller causes cancer. Business • 06 Oct 21
Bayer loses appeals case over glyphosate weedkiller Bayer lost a third appeal against US court verdicts that awarded damages to customers blaming their cancers on use of its glyphosate-based weedkillers, leaving the … Business • 10 Aug 21
Bayer sticks to $2bn provision after glyphosate ruling Bayer said today it was not increasing its $2 billion in provisions after a US judge rejected its class action plan to settle future claims … Business • 27 May 21
Bayer takes €9.25 billion writedown Bayer took impairment charges of €9.25 billion and said the costs of its settlement over claims its Roundup weedkiller causes cancer would be higher as … Business • 03 Nov 20
Bayer buys UK-based biotech KaNDy Therapeutics Bayer has agreed to acquire British biotech firm KaNDy Therapeutics for an initial $425 million, to strengthen its women's healthcare business with a prospective non-hormonal … Business • 11 Aug 20
Bayer agrees to pay $10.9bn to settle Roundup claims Bayer has agreed to settle thousands of US lawsuits claiming that its widely-used weed killer Roundup caused cancer for as much as $10.9 billion after … Business • 24 Jun 20
Bayer makes progress in settlement talks over Roundup Bayer said today it had made progress seeking a settlement over claims its glyphosate-based Roundup weedkiller causes cancer, after Bloomberg reported the company reached a … Business • 25 May 20
Bayer more stringent in glyphosate settlement talks Bayer said the economic downturn and the need to preserve cash means it is taking a tougher stance in talks to settle claims its glyphosate-based … Business • 27 Apr 20
EU bans Bayer pesticide linked to harming bees The European Commission has today decided not to renew approval for a pesticide linked to harming bees, effectively banning Bayer's insecticide known as thiacloprid. Business • 13 Jan 20
Number of glyphosate plaintiffs jumps to 42,700 - Bayer Bayer said the number of US plaintiffs blaming its glyphosate-based weedkillers for their cancer mushroomed to 42,700 from 18,400 in July, raising the stakes in … Business • 30 Oct 19
Lanxess, Bayer sell chemical park operator to Macquarie German chemical groups Bayer and Lanxess have agreed to sell integrated chemical site operator Currenta to Macquarie Infrastructure and Real Assets for an enterprise value … Business • 07 Aug 19
Bayer facing 18,400 US cases over glyphosate German pharmaceutical giant Bayer has said it is now targetted in some 18,400 US legal cases over glyphosate, a key herbicide ingredient that plaintiffs say … Business • 30 Jul 19
US judge slashes Roundup jury award to $25.3m A federal judge has cut a damages award Bayer owed a California man who blamed Roundup weed killer for his cancer, to $25.27m from $80.27m. Business • 16 Jul 19
Bayer to invest €5 billion in new weedkillers Bayer, the German crop science and chemicals group reeling from US litigation over claims its glyphosate pesticide causes cancer, said it would invest €5 billion … Business • 14 Jun 19
Bayer stock falls on $2 billion award in Roundup trial Shares in Bayer were down 5.9% today after a jury awarded more than $2 billion to a California couple in the largest US jury verdict … Business • 14 May 19
Bayer gets Monsanto profit boost but legal burden grows German drug and farming supplies company Bayer has today posted a 45% gain in quarterly core earnings thanks to the acquisition of seed maker Monsanto. Business • 25 Apr 19
Five things to know about Bayer and Monsanto The second cancer victim in a year to win a surprise victory against US pesticide maker Monsanto raises the prospect of a flood of similar … Business • 20 Mar 19
Investors flee Bayer after second Roundup trial blow The threat to German chemical giant Bayer and subsidiary Monsanto from US litigation swelled today, when its share price plunged after a jury ruled weedkiller … Business • 20 Mar 19
France bans weed-killer after court ruling French authorities have banned the sale of a form of controversial weed-killer Roundup following a court ruling that regulators failed to take safety concerns into … Europe • 15 Jan 19
US judge upholds Monsanto verdict but slashes award A US judge has upheld a jury verdict against Bayer subsidiary Monsanto in a historic case regarding the cancer danger of some of its weed … World • 23 Oct 18
